WHO ICTRP trial
CF-IDEA (Cystic Fibrosis - Insulin Deficiency, Early Action): Randomised…
ACTRN12611000068965 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12611000068965 |
|---|---|
| Public title | CF-IDEA (Cystic Fibrosis - Insulin Deficiency, Early Action): Randomised controlled trial of once-daily insulin detemir in patients with cystic fibrosis and early insulin deficiency |
| Scientific title | Randomised controlled trial to determine whether once-daily insulin detemir slows decline in weight and lung function in patients with cystic fibrosis and early insulin deficiency |
| Primary sponsor | Sydney Children's Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 / Phase 3 |
| Countries | Australia;United States of America |
| Conditions | Cystic Fibrosis;Insulin Deficiency; Cystic Fibrosis Insulin Deficiency;Respiratory - Other respiratory disorders / diseases |
| Interventions | Once-daily insulin detemir (Levemir) administered by subcutaneous injection for 12 months. Commencing dose 0.1 units/kg/day, titrated in 0.5 unit increments according to the results of home blood glucose monitoring. |
| Registration date | Jan 19, 2011 |
| Target size | 100 |
| Secondary IDs | ClinicalTrials.gov NCT01100892 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: